Exencial Wealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $385K | Buy |
3,470
+390
| +13% | +$43.2K | 0.01% | 407 |
|
|
2025
Q1 | $345K | Buy |
3,080
+95
| +3% | +$10.6K | 0.01% | 410 |
|
|
2024
Q4 | $276K | Sell |
2,985
-58
| -2% | -$5.36K | 0.01% | 430 |
|
|
2024
Q3 | $255K | Buy |
+3,043
| New | +$255K | 0.01% | 444 |
|
|
2024
Q2 | – | Sell |
-3,026
| Closed | -$222K | – | 489 |
|
|
2024
Q1 | $222K | Sell |
3,026
-2,262
| -43% | -$166K | 0.01% | 471 |
|
|
2023
Q4 | $428K | Buy |
5,288
+2,446
| +86% | +$198K | 0.02% | 357 |
|
|
2023
Q3 | $213K | Sell |
2,842
-218
| -7% | -$16.3K | 0.01% | 401 |
|
|
2023
Q2 | $236K | Buy |
3,060
+91
| +3% | +$7.01K | 0.01% | 402 |
|
|
2023
Q1 | $246K | Buy |
2,969
+255
| +9% | +$21.2K | 0.01% | 377 |
|
|
2022
Q4 | $233K | Buy |
+2,714
| New | +$233K | 0.01% | 390 |
|